Citation Impact
Citing Papers
The clinical symptoms of Parkinson's disease
2016 Standout
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
What contributes to quality of life in patients with Parkinson's disease?
2000 Standout
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
2008
Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study
2005
Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation
2011
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Parkinson disease
2017 Standout
Deep Brain Stimulation in Tourette’s Syndrome
2008
Inclusion body myositis and myopathies
1995 Standout
Inclusion body myositis: Clinical and pathological boundaries
1996
Parkinson's disease
2021 Standout
The role of sensory cues in the rehabilitation of parkinsonian patients: A comparison of two physical therapy protocols
2000
Parkinson's Disease
1998
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Fine‐motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome
2005
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology
2004
Epidemiology of psychosis in Parkinson's disease
2009
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Cognitive Deficits and Psychosis in Parkinson???s Disease
2006
Parkinson's disease: clinical features and diagnosis
2008 Standout
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
2000 Standout
Volitional action as perceptual detection: Predictors of conscious intention in adolescents with tic disorders
2014
Psychedelics
2016 Standout
Epidemiology of Parkinson's disease
2006 Standout
Selective diplopia in Parkinson's disease: A special subtype of visual hallucination?
2007
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects
2003
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
2008 Standout
Parkinson's disease
2009 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Sleep Disorders Associated with Parkinson's Disease:Role of Dopamine, Epidemiology, and Clinical Scales of Assessment
2008
Preliminary fMRI Evidence of Visual System Dysfunction in Parkinson's Disease Patients With Visual Hallucinations
2006
Bioactive compounds from natural resources against skin aging
2011
Psychotic symptoms in Parkinson’s disease
2005
Genetic Polymorphisms in Parkinson Disease Subjects With and Without Hallucinations
2004
The hallucinating brain: A review of structural and functional neuroimaging studies of hallucinations
2007 Standout
Brain response to complex visual stimuli in Parkinson's patients with hallucinations: A functional magnetic resonance imaging study
2008
Parkinson's disease
2015 Standout
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
2003
Pathophysiological distortions in time perception and timed performance
2011 Standout
Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition
2010
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors
2013
Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations
2010
Sydney multicenter study of Parkinson's disease: Non‐L ‐dopa–responsive problems dominate at 15 years
2004
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model
2004
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Hallucinations, Dreaming, and Frequent Dozing in Parkinson Disease: Impact of Right-hemisphere Neural Networks
2008
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
2019
Neuropathological Alterations in Alzheimer Disease
2011 Standout
Inclusion body myositis
2007
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
From psychosurgery to neuromodulation: Deep brain stimulation for intractable Tourette syndrome
2008
Sense of agency in the human brain
2017 Standout
Cerebral Metabolic Dysfunction in Patients with Dementia with Lewy Bodies and Visual Hallucinations
2008
Non-motor features of Parkinson disease
2017 Standout
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
2017
Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up
2002
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Psychosis, apathy, depression and anxiety in Parkinson's disease
2012
SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA
2000
Pathophysiology and Treatment of Psychosis in Parkinson’s Disease
2008
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
A systematic review of prevalence studies of dementia in Parkinson's disease
2005 Standout
Neurodegenerative diseases and oxidative stress
2004 Standout
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
2006
New approaches to understanding hallucinations in Parkinson’s disease: phenomenology and possible origins
2007
REVIEW: Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E
2007
The Association between Disease Severity and Sleep-Related Problems in Patients with Parkinson’s Disease
2002
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Polymyositis and dermatomyositis
2003 Standout
Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease
2008
D1 receptor agonist improves sleep–wake parameters in experimental parkinsonism
2013
Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations
2005
Vitamin E and Alzheimer disease: the basis for additional clinical trials
2000
Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom
2004
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches
2007
Prospective study of hallucinations and delusions in Parkinson's disease
2001
Parkinson's Disease
2003 Standout
Occupational and environmental risk factors for Parkinson's disease
2002
Chronic Inflammatory Disorders and Their Redox Control: From Molecular Mechanisms to Therapeutic Opportunities
2011
Relationship between age and subtypes of psychotic symptoms in Parkinson's disease
2007
Assessing mitochondrial dysfunction in cells
2011 Standout
Magnolol-based bio-epoxy resin with acceptable glass transition temperature, processability and flame retardancy
2020 Standout
Inflammatory Muscle Diseases
2015 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Vitamin E
2000
Hallucinations: The science of idiosyncratic perception.
2008
A Macrophage−Nanozyme Delivery System for Parkinson's Disease
2007
Tocopherols and total phenolics in 10 different nut types
2005 Standout
Altered cortical visual processing in PD with hallucinations
2004
Excessive daytime sleepiness in Parkinson’s disease
2004
Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase
2015
Vision assessment using the NIH Toolbox
2013 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Cortical Activations During Auditory Verbal Hallucinations in Schizophrenia: A Coordinate-Based Meta-Analysis
2010 Standout
The association of incident dementia with mortality in PD
2002
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Visual hallucinations in Parkinson's disease: Theoretical models
2014
Hallucinations in Parkinson's disease--a study of forty three patients.
2004
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Nocturnal symptom complex in PD and its management
2003
Thalamic Hyperperfusion in Verbal Hallucination of Parkinsonian Patients
2007
Works of Eric J. Pappert being referenced
Flu-like symptoms following botulinum toxin therapy
2011
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
1999
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients
1996
Advantages of a modified scoring method for the rush video-based tic rating scale
1999
Levodopa stability in solution: Time course, environmental effects, and practical recommendations for clinical use
1996
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation
1996
Objective assessments of longitudinal outcome in Gilles de la Tourette’s syndrome
2003
Prospective longitudinal assessment of hallucinations in Parkinson’s disease
2001
Intravenous levodopa in hallucinating Parkinson's disease patients
1998
Inclusion body myositis
1994
Buccal Mucosal Irritation Studies of Sublingual Apomorphine Film (APL-130277) in Syrian Golden Hamsters
2016
Poor visual discrimination and visual hallucinations in Parkinson's disease.
1998
Nonanimal Sourced Hyaluronic Acid–Based Dermal Filler Using a Cohesive Polydensified Matrix Technology is Superior to Bovine Collagen in the Correction of Moderate to Severe Nasolabial Folds
2010
Trauma and Movement Disorders
1992